Molecule intelOpportunity: ModerateEssentialCrowded market

Artesunate

113 brands · 40 companies · product forms

ATC: P01BE03

Opportunity snapshot

Launch attractiveness
37
Market saturation
92
Price room
100
Regulatory risk
0
113
brands
40
companies
Rs 212.08
median price
143
price points
27.71x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

Price room

Across observed sources and strengths
CheapestRs 44.72
MedianRs 212.08
Most expensiveRs 1,239.07
Spread27.71×
Sources: DRAP-official, DVAGO

max/min price ratio 27.71x across 143 trusted points (Rs 44.72-1239.07). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Artesunate — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(8) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

40 canonical companies and 113 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 27.71x across 143 trusted points (Rs 44.72-1239.07). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.